For CDKN1A, TIGAR, and PPM1D, although some genetic alterations were observed in BC cell lines (Fig. 4A) and tumor samples (Fig. 4B), no significant changes in gene expression were detected across different BC subtypes (Fig. 4C). This evidence concerns the gene TIGAR and breast cancer.